Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $26.4100 (4.72%) ($25.1000 - $27.8000) on Thu. Dec. 31, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.48% (three month average) | RSI | 39 | Latest Price | $26.4100(4.72%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.9% a day on average for past five trading days. | Weekly Trend | ATRA declines -3.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) IBB(53%) ARKG(50%) IWO(48%) ARKK(45%) | Factors Impacting ATRA price | ATRA will decline at least -3.74% in a week (0% probabilities). VIXM(-19%) TLT(-14%) UUP(-8%) UNG(-3%) SHY(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.74% (StdDev 7.48%) | Hourly BBV | 0 () | Intraday Trend | 4.8% | | | |
|
Resistance Level | $27.3 | 5 Day Moving Average | $24.55(7.58%) | 10 Day Moving Average | $24.18(9.22%) | 20 Day Moving Average | $27.3(-3.26%) | To recent high | -33.3% | To recent low | 25.8% | Market Cap | $1.962b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |